Takeda: Lack Of Realistic Upside In Japanese Pharma
Source: SeekingAlpha
2025-12-11 18:29:52 ET
I've been reviewing adjacent and peer pharma companies to Takeda (TAK) for some time, without looking at Takeda. So over the past few weeks, I looked more into Takeda and "did the work" to more closely analyze and cover it....
Read the full article on Seeking Alpha
For further details see:
Takeda: Lack Of Realistic Upside In Japanese Pharma
Takeda Pharmaceutical Company Limited American Depositary Shares
NASDAQ: TAK
TAK Trading
-0.63% G/L:
$18.115 Last:
1,281,262 Volume:
$18.15 Open:
TAK Latest News
March 02, 2026 02:00:00 am
Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera
February 24, 2026 09:35:00 am
Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity
TAK Stock Data
$57,107,745,653
3,115,826,299
N/A
157
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku
